AAAAAA
Results:
1-7
|
Results: 7
Authors:
Cerussi, AE
Berger, AJ
Bevilacqua, F
Shah, N
Jakubowski, D
Butler, J
Holcombe, RF
Tromberg, BJ
Citation: Ae. Cerussi et al., Sources of absorption and scattering contrast for near-infrared optical mammography, ACAD RADIOL, 8(3), 2001, pp. 211-218
Authors:
Hovanes, K
Li, TWH
Munguia, JE
Truong, T
Milovanovic, T
Marsh, JL
Holcombe, RF
Waterman, ML
Citation: K. Hovanes et al., beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer, NAT GENET, 28(1), 2001, pp. 53-57
Authors:
Holcombe, RF
Milovanovic, T
Stewart, RM
Brodhag, TM
Citation: Rf. Holcombe et al., Investigating the role of immunomodulation for colon cancer prevention: Results of an in vivo dose escalation trial of levamisole with immunologic endpoints, CANCER DET, 25(2), 2001, pp. 183-191
Authors:
Kannan, K
Holcombe, RF
Jain, SK
Alvarez-Hernandez, X
Chervenak, R
Wolfe, RE
Glass, J
Citation: K. Kannan et al., Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line, MOL C BIOCH, 205(1-2), 2000, pp. 53-66
Authors:
Holcombe, RF
Jacobson, J
Dakhil, SR
Stewart, RM
Betzing, KS
Kannan, K
Macdonald, JS
Citation: Rf. Holcombe et al., Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009, CANCER IMMU, 48(9), 1999, pp. 533-539
Authors:
Holcombe, RF
Jacobson, J
Li, AL
Moinpour, CM
Citation: Rf. Holcombe et al., Inclusion of black Americans in oncology clinical trials - The Louisiana State University Medical Center experience, AM J CL ONC, 22(1), 1999, pp. 18-21
Authors:
Holcombe, RF
Li, AL
Stewart, RM
Citation: Rf. Holcombe et al., Levamisole and Interleukin-2 for advanced malignancy, BIOTHERAPY, 11(4), 1998, pp. 255-258
Risultati:
1-7
|